PT1270555E - Metodo para oxidacao de um grupo tioeter em grupo sulfoxido - Google Patents

Metodo para oxidacao de um grupo tioeter em grupo sulfoxido

Info

Publication number
PT1270555E
PT1270555E PT01909846T PT01909846T PT1270555E PT 1270555 E PT1270555 E PT 1270555E PT 01909846 T PT01909846 T PT 01909846T PT 01909846 T PT01909846 T PT 01909846T PT 1270555 E PT1270555 E PT 1270555E
Authority
PT
Portugal
Prior art keywords
group
alkyl
tioeter
oxidizing
alkoxy
Prior art date
Application number
PT01909846T
Other languages
English (en)
Inventor
Berenguer Maimo Ramon
Campon Pardo Julio
Laura Coppi
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Publication of PT1270555E publication Critical patent/PT1270555E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT01909846T 2000-03-13 2001-03-08 Metodo para oxidacao de um grupo tioeter em grupo sulfoxido PT1270555E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000595A ES2163372B1 (es) 2000-03-13 2000-03-13 Procedimiento de oxidacion de un grupo tioeter a sulfoxido.

Publications (1)

Publication Number Publication Date
PT1270555E true PT1270555E (pt) 2005-01-31

Family

ID=8492674

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01909846T PT1270555E (pt) 2000-03-13 2001-03-08 Metodo para oxidacao de um grupo tioeter em grupo sulfoxido

Country Status (16)

Country Link
US (1) US6603009B2 (pt)
EP (1) EP1270555B1 (pt)
JP (1) JP5041646B2 (pt)
KR (1) KR100657094B1 (pt)
CN (1) CN1229341C (pt)
AT (1) ATE274492T1 (pt)
AU (2) AU3745201A (pt)
CA (1) CA2402635C (pt)
DE (1) DE60105139T2 (pt)
ES (2) ES2163372B1 (pt)
HU (1) HUP0301885A2 (pt)
MX (1) MXPA02008961A (pt)
NO (1) NO20024239D0 (pt)
NZ (1) NZ521071A (pt)
PT (1) PT1270555E (pt)
WO (1) WO2001068594A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1781918A (zh) 2001-02-02 2006-06-07 特瓦制药工业有限公司 制备硫酯化合物的方法
KR100464174B1 (ko) * 2002-03-06 2005-01-03 코오롱유화주식회사 설피닐 벤즈이미다졸 유도체의 제조방법
ATE375338T1 (de) 2002-08-21 2007-10-15 Teva Pharma Verfahren zur aufreinigung von lanzoprazol
DE03789888T1 (de) 2002-11-18 2005-08-18 Teva Pharmaceutical Industries Ltd. Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol
US7507829B2 (en) 2002-12-19 2009-03-24 Teva Pharmaceuticals Industries, Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
US7678816B2 (en) 2003-02-05 2010-03-16 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
EP1615913A2 (en) * 2003-06-10 2006-01-18 Teva Pharmaceutical Industries Limited Process for preparing 2-(pyridinyl)methyl sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
WO2006013960A1 (ja) 2004-08-06 2006-02-09 Eisai R & D Management Co., Ltd. ベンズイミダゾール誘導体とアミンとの塩およびその製造方法
US7915422B2 (en) 2004-10-11 2011-03-29 Ranbaxy Laboratories Limited Processes for the preparation of substituted sulfoxides
KR100771659B1 (ko) 2005-03-23 2007-10-30 주식회사 카이로제닉스 판토프라졸 및 그 중간체의 제조방법
CN1919844B (zh) * 2006-09-01 2010-05-12 武汉工程大学 水相氧化合成兰索拉唑的方法
WO2009066309A2 (en) * 2007-07-12 2009-05-28 Cadila Healthcare Limited Process for preparation of omeprazole
US20100210847A1 (en) * 2007-07-17 2010-08-19 Ranbaxy Laboratories Limited Process for the preparation of pantoprazole sodium and pantoprazole sodium sesquihydrate
CN102161633A (zh) * 2011-02-22 2011-08-24 苏州科同生物医药科技有限公司 亚砜类有机化合物的制备方法
CN103044399B (zh) * 2011-10-12 2014-08-06 北大方正集团有限公司 一种雷贝拉唑及其钠盐的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
ES2036948B1 (es) * 1991-11-21 1994-09-01 Genesis Para La Investigacion Procedimiento de obtencion de compuestos derivados de piridina.
ES2060541B1 (es) * 1993-02-26 1995-11-16 Vinas Lab Nuevo procedimiento para la sintesis de un derivado de 2-(2-piridilmetilsufinil) bencimidazol, y nuevos productos intermedios obtenidos con el mismo.
CA2295817C (en) * 1997-07-11 2008-02-12 Eisai Co., Ltd. Method for producing pyridine compound
US6437189B1 (en) * 1997-12-12 2002-08-20 Bayer Corporation Synthesis of sulfoxides via selective oxidation of sulfides with a perborate or a percarbonate
ES2185459B1 (es) * 2000-10-02 2003-12-16 Dinamite Dipharma Spa Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo.

Also Published As

Publication number Publication date
EP1270555B1 (en) 2004-08-25
NO20024239L (no) 2002-09-05
JP5041646B2 (ja) 2012-10-03
CN1418188A (zh) 2003-05-14
AU2001237452B9 (en) 2005-01-27
US6603009B2 (en) 2003-08-05
NO20024239D0 (no) 2002-09-05
AU2001237452B2 (en) 2005-01-13
JP2003527370A (ja) 2003-09-16
KR20030007461A (ko) 2003-01-23
ES2227145T3 (es) 2005-04-01
US20030028030A1 (en) 2003-02-06
DE60105139D1 (de) 2004-09-30
DE60105139T2 (de) 2005-09-15
KR100657094B1 (ko) 2006-12-12
ES2163372A1 (es) 2002-01-16
CN1229341C (zh) 2005-11-30
MXPA02008961A (es) 2004-10-15
CA2402635C (en) 2008-07-08
HUP0301885A2 (hu) 2003-09-29
EP1270555A1 (en) 2003-01-02
WO2001068594A1 (es) 2001-09-20
AU3745201A (en) 2001-09-24
ES2163372B1 (es) 2003-05-01
ATE274492T1 (de) 2004-09-15
CA2402635A1 (en) 2001-09-20
NZ521071A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
PT1270555E (pt) Metodo para oxidacao de um grupo tioeter em grupo sulfoxido
EA200200481A1 (ru) Способ получения производных 4-трифторметилсульфинилпиразола
DK1392642T3 (da) Hidtil ukendte forbindelser som anti-inflammatoriske, immunmodulatoriske og antiproliferative midler
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
AR029280A1 (es) Método de tratamiento de sustratos minerales
DK1673338T3 (da) Forbindelser afledt af fedtsyrer, fremstilling og anvendelse
DE69811117D1 (de) Tetrahydrothiopyran-phenyloxazolidinon-s-oxide
ATE435848T1 (de) Stabilisierte zusammensetzungen einer wässrigen lösung von reduziertem coenzym q
CO5650218A2 (es) Composiciones de enjuague bucal que contienen sales del alquil ester de n-acil arginina
DE60233664D1 (de) Verfahren zur herstellung von pyridinverbindungen
DE60015390D1 (de) Antidiabetische thiazolidindione und ihre herstellung
EP1357124A4 (en) HETEROCYCLIC COMPOUNDS AND COMPOSITIONS IMPROVING CEREBRAL FUNCTIONS CONTAINING THESE AS ACTIVE INGREDIENTS
DE60238116D1 (de) Halogenierte chinolinderivate und mittel zur bekämpfung von ectoparasiten
BR0009453B1 (pt) processo para a preparação de um composto.
IT1319663B1 (it) Processo per la preparazione di fluoro-steroidi.
DK1156058T3 (da) Fremgangsmåde til fremstilling af (E,Z) 3-(2-aminoethoxyimino)-androstan-6,17-dion og analoger deraf
BRPI0206922B8 (pt) composto de fragrância, composição de fragrância contendo o mesmo, e método para preparação de um composto de fragrância
ATE404551T1 (de) 3-hydroxymethylbenzo b thiophen-derivate und verfahren zu deren herstellung
ATE299874T1 (de) Verfahren zur herstellung von 3-arylbenzofuran-2- onen
BR0210201A (pt) Composição
DK0979822T3 (da) Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner
ATE350069T1 (de) Potenziertes und stabilisiertes desinfektionsmittel mit bakterizider und viruzider wirkung
DE60230924D1 (de) 2-substituierte vitamin-d-derivate
ATE333870T1 (de) Blockade der natriumkanäle durch phenolderivate